Drugs against articular failure
a technology for articular failure and drugs, applied in the direction of drug compositions, chewing gum, biocide, etc., can solve the problems of increasing the crisis rate of articular disorders, articular disorders becoming a social problem, and exposure to risks such as inflammation and physical destruction, and achieve satisfying taste and flavor
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Benefits of technology
Problems solved by technology
Method used
Examples
example 2
Agent For Treating Articular Disorders
[0049] Three and half parts by weight of crystalline hydrous trehalose ("TREHA.RTM.", commercialized by Hayashibara Shoji Inc., Okayama, Japan), one part by weight of glucosamine ("NATURAL GLUCOSAMINE.TM.", commercialized by Yaizu Suisankagaku Industry Co., Ltd., Shizuoka, Japan) and 0.5 part by weight of chondroitin 4-sulfate ("MUCOTEIN-DK.TM.", commercialized by Yaizu Suisankagaku Industry Co., Ltd., Shizuoka, Japan) were mixed well to obtain the captioned product in the form of a powder.
[0050] Since the product remarkably exerts an action on articular disorders and has mild sweetness, it is useful to prevent or alleviate articular disorder such as arthritis and rheumatoid as a health food. The product can be used as a health food in the form of a tablet produced by a conventional tableting method, and it can be also used in foods, cosmetics and pharmaceuticals as an additive for imparting or supplementing the action for articular disorders.
example 3
Agent For Treating Articular Disorders
[0051] Four parts by weight of crystalline hydrous trehalose ("TREHA.RTM.", commercialized by Hayashibara Shoji Inc., Okayama, Japan), one part by weight of N-acetylglucosamine ("MARINE SWEET.TM.", commercialized by Yaizu Suisankagaku Industry Co., Ltd., Shizuoka, Japan), 0.5 part by weight of chondroitin 4-sulfate ("MUCOTEIN-DK.TM.", commercialized by Yaizu Suisankagaku Industry Co., Ltd.) and 0.1 part by weight of 2-O-alpha-D-glucopyranosyl L-ascorbic acid ("AA-2G.RTM.", commercialized by Hayashibara Shoji Inc., Okayama, Japan) were mixed well to obtain the captioned product in a powder form.
[0052] Since the product remarkably exerts the action for treating articular disorders and has mild sweetness, it is useful to prevent or alleviate articular disorder such as arthritis and rheumatoid as a health food. The product can be used as a health food in the form of a tablet produced by a conventional tableting method, and it can be also used in foo...
example 4
Agent For Treating Articular Disorders
[0053] Five hundreds fifty parts by weight of fine powdery crystalline hydrous aluminum silicate, 50 parts by weight of boric acid, 400 parts by weight of condense glycerin, four parts by weight of camphor, 0.5 parts by weight of peppermint oil, 10 parts by weight of crystalline anhydrous maltitol ("MABIT.RTM." (granule type), commercialized by Hayashibara Shoji Inc., Okayama, Japan) and 60 parts by weight of the agent for treating articular disorders of Example 1 were placed in a heat-resistant vessel and mixed well in a hot water bath to obtain the captioned product in a gel form.
[0054] Since the product can be used by attaching to the skin similarly as in conventional hot cataplasms, it can be used as a cataplasm to prevent or cure articulation disorders in various fields of pharmaceuticals, etc.
PUM
Property | Measurement | Unit |
---|---|---|
Dimensionless property | aaaaa | aaaaa |
Time | aaaaa | aaaaa |
Time | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com